BRIEF published on 06/14/2024 at 15:05, 1 year 9 months ago Reinet Investments SCA Announces Transactions by Managers Market Abuse Regulation Share Transactions Managerial Responsibilities Reinet Investments European Union
BRIEF published on 06/14/2024 at 15:05, 1 year 9 months ago Reinet Investments SCA annonce des transactions par les gestionnaires Union Européenne Réglementation Sur Les Abus De Marché Partager Des Transactions Reinet Investissements Responsabilités Managériales
BRIEF published on 06/14/2024 at 15:05, 1 year 9 months ago Seraxis Secures $400,000 Maryland Stem Cell Research Fund Grant for Pancreatic Islet Replacement Therapy Stem Cell Research Seraxis Pancreatic Islet Replacement Type 1 Diabetes MSCRF Grant
BRIEF published on 06/14/2024 at 15:05, 1 year 9 months ago Seraxis obtient une subvention du Maryland Stem Cell Research Fund de 400 000 $ pour le traitement de remplacement des îlots pancréatiques Recherche Sur Les Cellules Souches Seraxis Remplacement Des Îlots Pancréatiques Diabète De Type 1 Subvention MSCRF
BRIEF published on 06/14/2024 at 15:05, 1 year 9 months ago Peerless Pump's FireConnect® Product Receives FM Approval Under FM Standard 1330 Remote Monitoring Peerless Pump FireConnect® FM Approval Fire Protection
BRIEF published on 06/14/2024 at 15:05, 1 year 9 months ago Le produit FireConnect® de Peerless Pump reçoit l'approbation FM selon la norme FM 1330 Surveillance À Distance FireConnect® Pompe Sans Égal Approbation FM Protection Contre Le Feu
BRIEF published on 06/14/2024 at 14:57, 1 year 9 months ago Cardiol Therapeutics Inc Receives Updated 'Buy' Rating from First Berlin Equity Research BUY Rating Cardiol Therapeutics CardiolRx Recurrent Pericarditis Phase II Study
BRIEF published on 06/14/2024 at 14:57, 1 year 9 months ago Cardiol Therapeutics Inc reçoit une note « d'achat » mise à jour de la part de First Berlin Equity Research Acheter Une Note CardiolRx Cardiol Thérapeutique Péricardite Récurrente Étude De Phase II
BRIEF published on 06/14/2024 at 14:57, 1 year 9 months ago TIKEHAU CAPITAL : Déclaration des Transactions sur Actions Propres Actions Propres Transactions Europe Réglementation MAR Tikehau Capital
BRIEF published on 06/14/2024 at 14:57, 1 year 9 months ago TIKEHAU CAPITAL: Declaration of Transactions on Own Shares Transactions Europe Own Shares MAR Regulations Tikehau Capital
Published on 04/09/2026 at 14:00, 3 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 33 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 33 minutes ago ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel
Published on 04/09/2026 at 13:30, 33 minutes ago ROK Resources Announces 2026 Capital Budget and 2025 Year-End Reserves
Published on 04/09/2026 at 13:30, 33 minutes ago Eskay Mining Corp. Deploys AI-Powered Investor Relations Agent to Deliver Unprecedented Transparency
Published on 04/09/2026 at 13:45, 17 minutes ago EDGX launches first in-orbit demonstration of its AI computing system on SpaceX Transporter-16
Published on 04/09/2026 at 13:33, 30 minutes ago Coreline Soft Aligns with Germany's New Lung Cancer Screening Reimbursement Framework from 2026, New Operational Requirements Introduced for Hospitals and Screening Programs
Published on 04/09/2026 at 13:33, 30 minutes ago Phemex TradFi Crude Oil Trading Surges 300% as Ceasefire Volatility Sparks Record Demand
Published on 04/09/2026 at 13:33, 30 minutes ago Terra Quantum AG to go public in $3.25 billion SPAC deal
Published on 04/09/2026 at 12:30, 1 hour 33 minutes ago Immunic to Participate in Scientific and Medical Conferences in April
Published on 04/09/2026 at 07:00, 7 hours 3 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/09/2026 at 07:00, 7 hours 3 minutes ago bioMérieux lance sa solution de diagnostic moléculaire BIOFIRE® SPOTFIRE® pour l’industrie pharmaceutique afin de renforcer le dépistage rapide des mycoplasmes
Published on 04/08/2026 at 18:17, 19 hours 45 minutes ago Mise à disposition du Rapport sur la solvabilité et la situation financière 2025 du Groupe des Assurances du Crédit Mutuel
Published on 04/08/2026 at 18:16, 19 hours 46 minutes ago Mise à disposition des états financiers 2025 du Groupe des Assurances du Crédit Mutuel
Published on 04/08/2026 at 18:02, 20 hours 1 minute ago Publication of the 2025 Universal Registration Document
